Apoptosis in AIDS

Apoptosis

Volumn 6, Issue 1-2, 2001, Pages 103-116

  Roshal, M ^a   Zhu, Y ^a   Planelles, V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

AIDS; Apoptosis; env; HIV; net; Survival; tat; vpr

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS GENE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APOPTOSIS; HIV-1; HUMANS; T-LYMPHOCYTES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035076038     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009636530839     Document Type: Review

References (175)

1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
2. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
3. Viral dynamics in human immunodeficiency virus type 1 infection
4. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome
5. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis
6. Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS
7. Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis
8. Indirect mechanisms of HIV pathogenesis: How does HIV kill T cells?
9. The cytopathic effect of HIV is associated with apoptosis
10. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
11. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals
12. Programmed death of T cells in HIV-1 infection
13. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
14. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
15. Human immunodeficiency viruses and their replication
16. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
17. Call-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
18. Transcomplementation of VIF-HIV-1 mutants in CEM cells suggests that VIF affects late steps of the viral life cycle
19. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
20. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
21. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
22. Human immunodeficiency virus type 1-associated CD4 downmodulation
23. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum
24. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4
25. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: A predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity
26. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses
27. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release
28. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules
29. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
30. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1
31. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
32. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells
33. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
34. Endocytosis and targeting of exogenous HIV-1 Tat protein
35. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
36. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
37. Checkpoints: Controls that ensure the order of cell cycle events
38. When checkpoints fail
39. Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat- activation
40. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression
41. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
42. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes
43. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1
44. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
45. Grb3-3 is up-regulated in HIV-1 infected T-cells and can potentiate cell activation through NFATc
46. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1
47. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1
48. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors
49. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein
50. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes
51. Differential requirement for p561ck in HIV-tat versus TNF- induced cellular responses: Effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis
52. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB
53. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines
54. HIV-1tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line
55. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells
56. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase
57. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells
58. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state
59. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis
60. Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein
61. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells
62. Expression of human immunodeficiency virus type I tat results in down- regulation of bcl-2 and induction of apoptosis in hematopoietic cells
63. Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms
64. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
65. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation
66. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3
67. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates
68. Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR
69. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells
70. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity
71. Dual role of HIV Tat in regulation of apoptosis in T cells
72. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines
73. HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals
74. Human immunodeficiency virus vpr product is a virion-associated regulatory protein
75. Mutational analysis of the human immunodeficiency virus vpr open reading frame
76. Cooperative interaction between HIV-1 regulatory proteins Tar and Vpr modulates transcription of the viral genome
77. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate
78. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
79. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm)
80. Human immunodeficiency virus vpr gene encodes a virion-associated protein
81. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import
82. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
83. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
84. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex
85. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
86. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines
87. Human immunodeficiency virus type 1 Vpr localization: Nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity
88. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
89. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
90. Vpr-induced cell cycle arrest is conserved among primate lentiviruses
91. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B
92. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
93. Differential apoptosis effects of primate lentiviral vpr and vpx in mammalian cells
94. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr
95. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
96. Induction of M-phase arrest and apoptosis after HIV-1 vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells
97. HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae
98. Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of weel, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr
99. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities
100. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast
101. Mutational analysis of cell cycle arrest, nuclear localization and vi. packaging of human immunodeficiency virus type 1 Vpr
102. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects
103. Role of the conserved dipeptide Gly75 and Cys76 on HIV-1 Vpr function
104. Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest
105. Multiple centrosome formation induced by the expression of Vpr gene of human immunodeficiency virus
106. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
107. Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard
108. Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus
109. Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1
110. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1
111. Human immunodeficiency virus type 1 Vpt protein binds to the uracil DNA glycosylase DNA repair enzyme
112. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of scooty mangabeys, but binding does not correlate with cell cycle arrest
113. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair
114. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate
115. HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr
116. p53 and ATM: Cell cycle, cell death, and cancer
117. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
118. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
119. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
120. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression
121. The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: Possible implications for the pathogenesis of AIDS
122. The HIV-1 Vpr displays strong anti-apoptotic activity
123. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells
124. HIV-1 tropism and co-receptor use
125. Coreceptors: Implications for HIV pathogenesis and therapy
126. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCRS
127. The CD4 molecule transmits biochemical information important in the regulation of T lymphocyte activity
128. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
129. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule
130. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells
131. CD4+ blood lymphocytes are rapidly killed in vitro by contact wit autologous human immunodeficiency virus-infected cells
132. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals
133. The cell death-inducing ability of glycoprotein 120 from different HIV strains correlates with their ability to induce CD4 lateral association with CD95 on CD4+ T cells
134. Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2
135. Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1
136. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: A possible mechanism of bystander cell death in HIV infection
137. Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis
138. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway
139. Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro
140. Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells
141. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor- alpha secretion
142. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells
143. HIV-1 gp120- and gp 160-induced apoptosis in cultured endothelial cells is mediated by caspases
144. CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells
145. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120)
146. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling
147. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
148. Importance of the nef gene for maintenance of high virus load and for development of AIDS
149. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
150. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef
151. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
152. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes
153. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
154. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef
155. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 Production increases progeny particle infectivity independently of gp160 or viral entry
156. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis
157. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation
158. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell
159. Interactions of HIV-1 NEF with cellular signal transducing proteins
160. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14
161. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain
162. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells
163. Human immunodeficiency virus type 1 Nef protien sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway
164. Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) zeta chain leads to TCR downmodulation
165. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2
166. The T-cell receptor zeta chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation
167. A novel kinase activity associated with Nef derived from neurovirulent simian immunodeficiency virus
168. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex
169. p21-activated kinase 1 plays a critical role in cellular activation by Nef
170. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase
171. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family
172. Identification of the Nef-associated kinase as p21-activated kinase 2
173. Human immunodeficieny virus type 1 Nef associates with a cellular serine kinase in T lymphocytes
174. Caspase-mediated activation of PAK2 during apoptosis: Proteolytic kinase activation as a general mechanism of apoptotic signal transduction?
175. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2